Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
311
-
Total 13F shares, excl. options
-
72.1M
-
Shares change
-
-1.2M
-
Total reported value, excl. options
-
$2.6B
-
Value change
-
-$54.2M
-
Put/Call ratio
-
0.06
-
Number of buys
-
165
-
Number of sells
-
-139
-
Price
-
$36.02
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q4 2024
388 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q4 2024.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 311 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.1M shares
.
Largest 10 shareholders include BlackRock, Inc. (11.7M shares), VANGUARD GROUP INC (7.44M shares), STATE STREET CORP (2.77M shares), ArrowMark Colorado Holdings LLC (2.72M shares), GW&K Investment Management, LLC (2.12M shares), FRED ALGER MANAGEMENT, LLC (1.94M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (1.66M shares), Park West Asset Management LLC (1.6M shares), Stephens Investment Management Group LLC (1.56M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.53M shares).
This table shows the top 311 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.